HealthStream Stock Price and Value Analysis

HealthStream (NasdaqGS:HSTM) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold HealthStream to reach your target.

Target type

HSTM Free Cash Flow Trend

Free Cash Flow trendline for HSTM
Free Cash Flow trendline for HealthStream
CSV

Based on historical returns, we believe that HealthStream can grow its free cash at a rate of about 12%. That's positive!

AdvantagesDisadvantages
  • This company is making money at a great rate!
  • This company has stable growth.
  • This company is solid.
  • This stock is available at a great discount!
  • This company has a low dividend yield.

Inside the HSTM Numbers

HSTM Price
(HealthStream stock price per share)
$26.29
[?] HSTM Fair Price
(based on intrinsic value)
$49.45
[?] HSTM Safety Price (based on a variable margin of safety) $32.14
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 128% higher than other Technology stocks
[?] PE Ratio versus Industry 66% higher than other Information Technology Services stocks
[?] Cash Yield 5.45%
[?] Free Cash Flow Jitter 24%
[?] Dividend Yield 0.52% (tax impact)
Shares Shorted 1,178,710

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,178,710 shares shorted. With 21,976,092 shares available for purchase and an average trading volume over the past 10 trading days of 264,400, it would take at least 4.5 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 1095565 9.8
2010 1095565 13.9
2011 1095565 16.9
2012 1095565 19.3
2013 1095565 22.8
2014 1095565 30.2
2015 1095565 29.8
2016 1095565 19
2017 1095565 41.2
2018 1095565 37.2
2019 1095565 56.1
2020 1095565 27.6
2021 1095565 30.4
2022 1095565 35.1
2023 1095565 43.9
2024 1095565 41.7
2025 1095565 47

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2009 to 2025 with positive net income, operating cash flow totaled $660 million against net income of $207 million, or 3.18 times.

In 2025, operating cash flow was 3.45 times net income, compared with 1.89 times for the earliest three years (2009 to 2011).

In 2025, capital expenditures were $3.7 million, 5.8% of operating cash flow of $63.3 million, which leaves an estimated $59.6 million after capex. Across the 17 years with reported capex, it averaged 23.2% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 14 11.6 1.8 0.83
2010 4.2 16.1 2.6 3.88
2011 6.9 19.8 4.1 2.84
2012 7.6 22.5 4.3 2.95
2013 8.4 26.3 4.4 3.12
2014 10.4 34.3 4.5 3.30
2015 8.6 34.9 8.1 4.05
2016 3.8 24.2 4.8 6.45
2017 10 46.7 5.5 4.67
2018 32.2 43.2 7.2 1.34
2019 15.8 65.7 22 4.16
2020 14.1 35.9 2 2.55
2021 5.8 42.4 23.4 7.25
2022 12.1 51.2 25.9 4.23
2023 15.2 64 27.3 4.20
2024 20 57.7 1.4 2.88
2025 18.3 63.3 3.7 3.45

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 9 fiscal years from 2010 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $333 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 7 of those years with dividend payment facts, dividends paid totaled $42.7 million, 15.0% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 7 of those 7 years.

In 5 of the 9 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $87.1 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $33.7 million, 71.8% of estimated free cash flow of $47 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2010 13.9 n/a 0.4 0.4 2.7%
2018 37.2 32.4 n/a 32.4 86.9%
2019 56.1 0.1 n/a 0.1 0.1%
2020 27.6 0 20 20.1 72.7%
2021 30.4 0 5 5 16.6%
2022 35.1 n/a 23.1 23.1 65.9%
2023 43.9 3.1 8.9 12 27.4%
2024 41.7 3.4 n/a 3.4 8.2%
2025 47 3.7 30 33.7 71.8%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $57.4 million in 2009 and $304 million in 2025, a compound annual growth rate of 11.0% over 16 years.

Revenue rose 4.3% from 2024 to 2025.

Our estimated free cash flow was $47 million in 2025, 15.5% of revenue. In 2009 the estimated margin was 17.0%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2009 57.4 9.8 17.0%
2010 65.8 13.9 21.2%
2011 82.1 16.9 20.6%
2012 104 19.3 18.6%
2013 132 22.8 17.3%
2014 171 30.2 17.7%
2015 209 29.8 14.3%
2016 226 19 8.4%
2017 248 41.2 16.6%
2018 232 37.2 16.1%
2019 254 56.1 22.1%
2020 245 27.6 11.3%
2021 257 30.4 11.8%
2022 267 35.1 13.2%
2023 279 43.9 15.7%
2024 292 41.7 14.3%
2025 304 47 15.5%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $36.2 million against total liabilities of $166 million, or 21.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 32.0% of total assets in 2025, compared with 30.8% in 2010, an increase of 1.2 percentage points.

Stockholders equity was $354 million in 2025, compared with $56.8 million in 2010, a rise of 523.4%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 13.0% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 82 17.9 25.2 56.8
2011 154 76.9 33.3 121
2012 175 41.4 42.3 132
2013 213 59.5 63.2 149
2014 257 82 89.4 168
2015 380 82 99.2 280
2016 396 49.6 110 286
2017 411 84.8 111 300
2018 442 134 123 319
2019 490 132 151 338
2020 500 36.6 166 334
2021 487 46.9 148 339
2022 498 46 164 334
2023 500 40.3 159 341
2024 511 59.5 151 359
2025 520 36.2 166 354

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $26.29, our model's value equals that price if free cash flow grows an average of -1.3 percent a year over the 10 projection years. Our model assumes 11.6 percent a year for this stock, so the price implies growth of -1.3 percent, which is below the 11.6 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

A negative rate means the price matches our model's value only if free cash flow shrinks by that average each year over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $43.8 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $21.03 -7.5%
Current price $26.29 -1.3%
20 percent above the current price $31.55 2.9%
Our model (stored fair price) $49.45 11.6%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Free cash flow was positive in all 17 fiscal years we have for HealthStream under its current SEC filer.

With the price at $26.29, HealthStream is below both our safe value ($32.14) and our fair value ($49.45).

The latest three years average $44.2 million in free cash flow against $13.5 million for the earliest three, which is a sharp rise.

Year-to-year variability in free cash flow is fairly steady, measured at 24%.

Its dividend yield is 0.52%.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 128% above the average for stocks in the Technology sector.

Its trailing P/E ratio is 66% above the average for stocks in the Information Technology Services industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Information Technology Services industry, the ones closest in market capitalization to HealthStream, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
HealthStream (HSTM) 804 37.6 0.5% 5.4% 47% below
TripAdvisor (TRIP) 826 - - 25.4% 89% below
Cars.com (CARS) 643 16.7 - - 36% above
Simulations Plus (SLP) 374 46.2 - 1.9% 37% below
Asure Software (ASUR) 316 - - - 60% above
Ribbon Communications (RBBN) 222 12.3 - - 51% below
CSP (CSPI) 73.9 - 1.6% - 66% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1095565.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: HSTM annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in HSTM

Does HealthStream have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: HSTM

This example shows how we apply the Trendshare checklist to HSTM: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 26.29
    • Market cap: $804M
    • EPS: 0.7
  2. Step 2 — Valuation checks

    • P/E: 37.557
    • FCF yield: 5.4%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.